Radiological differentiation between bacterial orbital cellulitis and invasive fungal sino-orbital infections
International Ophthalmology · 2024
DOI: 10.1007/s10792-024-03241-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, 2024. Verfasst von Terence Ang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The University of Adelaide, Adelaide, SA, Australia. terence.ang@adelaide.edu.au. Hauptthemen laut MEDLINE: Orbital Cellulitis, Eye Infections, Fungal, Magnetic Resonance Imaging, Eye Infections, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Adelaide.
Abstract (Originalsprache)
Purpose
Invasive fungal orbital infections (IFOI) may be difficult to differentiate from sinogenic bacterial orbital cellulitis (OC). This study investigates the features differentiating OC from IFOI on magnetic resonance imaging (MRI).
Methods
Retrospective study of adult patients with sinogenic OC and IFOI with pre-intervention MRI. Patients without post-septal involvement, non-sinogenic OC (e.g.: secondary to trauma) and poor-quality scans were excluded. Independent Sample’s t test and Fisher’s exact test were conducted with p < 0.05 deemed statistically significant.
Results
Eleven cases each of OC (Mean age: 41.6 ± 18.4 years-old, Male: 10) and IFOI (Mean age: 65.0 ± 16.6 years-old, Male: 9) between 2006 and 2023. IFOI patients were older, more likely immunocompromised and had a lower mean white-cell count ( p value = 0.005, 0.035 and 0.017, respectively). The ethmoid and maxillary sinuses were most commonly involved in both entities. Pre-septal and lacrimal gland involvement were more common in OC ( p = 0.001 and 0.008, respectively). Infiltrative OC orbital lesions were poorly demarcated, whilst those in IFOI were expansile/mass-like invading the orbit from the adjacent paranasal sinuses. Specific IFOI features included loss-of-contrast-enhancement (LoCE) of paranasal sinus tissues with orbital extension. Extra-orbital and -sinonasal extension indicative of IFOI included contiguous skull base or pterygopalatine fossa involvement, retro-antral and masticator space stranding and vasculitis.
Conclusion
This study describes the key MRI features of IFOI including differentiating markers from OC. These specific features, such as LoCE of the paranasal and orbital soft tissues, the location and pattern of contiguous soft-tissue involvement, provide expedient identification of IFOI which necessitate early surgical intervention for microbiological confirmation of an invasive fungal pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The University of Adelaide, Adelaide, SA, Australia. terence.ang@adelaide.edu.au.
- Department of Ophthalmology, The Royal Adelaide Hospital, Adelaide, SA, 5000, Australia. terence.ang@adelaide.edu.au.
- The University of Adelaide, Adelaide, SA, Australia.
- Department of Medical Imaging, The Royal Adelaide Hospital, Adelaide, SA, Australia.
- Jones Radiology, Adelaide, SA, Australia.
- Department of Ophthalmology, The Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.
Förderung
- The University of Adelaide
Zitieren
APA
Ang, T., Lim, W., Chaggar, V., Patel, S., & Selva, D. (2024). Radiological differentiation between bacterial orbital cellulitis and invasive fungal sino-orbital infections. International Ophthalmology. https://doi.org/10.1007/s10792-024-03241-3
Vancouver
Ang T, Lim W, Chaggar V, Patel S, Selva D. Radiological differentiation between bacterial orbital cellulitis and invasive fungal sino-orbital infections. International Ophthalmology. 2024. doi:10.1007/s10792-024-03241-3
BibTeX
@article{Ang2024,
author = {Ang, Terence and Lim, Wanyin and Chaggar, Viraj and Patel, Sandy and Selva, Dinesh},
title = {Radiological differentiation between bacterial orbital cellulitis and invasive fungal sino-orbital infections},
journal = {International Ophthalmology},
year = {2024},
doi = {10.1007/s10792-024-03241-3}
}
EUVIMED